Core OTA business delivered healthy growth. In 3Q25, TC's core OTAbusiness revenue reached RMB4.6bn (83.7% of total revenue), up 14.9%YoY (2Q25: 13.7% YoY), and was 0.4% ahead of consensus driven bybetter- than-expected revenue growth in accommodation reservationservices and others. In 3Q25, transportation ticketing services/accommodation reservation services/other revenue achieved YoY growthof 9.0%/14.7%/34.9% (2Q25: 7.9%/15.2%/27.5%). The 12-monthaccumulated number of travellers served reached 2.0bn by en ...

Later, we'll celebrate and reward the winning ideas, those with the potential not just to improve the future, but to actually redefine it. Our purpose today is to strengthen the innovation ecosystem through idea chains, inspiration across industries and international perspectives. We are very excited to welcome here today representatives from all major Greek banks, leading Greek organizations, members of the Greek government, innovative start-ups, venture capital firms and partners such as Microsoft, IBM, E ...

Vancouver, British Columbia--(Newsfile Corp. - November 28, 2025) - District Metals Corp. (TSXV: DMX) (Nasdaq First North: DMXSE SDB) (OTCQX: DMXCF) (FSE: DFPP); ("District" or the "Company") is pleased to report its results for the three months ended September 30, 2025. All amounts are in Canadian dollars, unless otherwise noted. Financial and Operational Update On November 5, 2025, the Swedish Parliament voted to repeal the moratorium on uranium exploration and mining in Sweden, imposed in 2018, and appro ...

Considering buying VSTS stock? Here's what analysts think: On Aug. 5, Vestis posted better-than-expected results for the third quarter. Shares of Vestis gained 1.6% to close at $6.44 on Wednesday. Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables. Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period. Vestis Corporation (NYSE: ...

SHENZHEN, China, Nov. 28, 2025 (GLOBE NEWSWIRE) -- SENO secured 700k in pre seed funding to accelerate research, testing, and platform development for its film based delivery technology while preparing for future technical evaluations in global markets. Strategic Capital to Strengthen Research and Platform Development SENO, an emerging technology company focused on the development of next generation ultra thin film delivery systems, announced the completion of its 700,000 USD pre seed fundraising round. The ...

Why an OUTPERFORM rating? 机构：中金公司 研究员：Wenjie ZHANG/Qibin FENG/Xin YANG Investment positives We initiate coverage of Anhui Expressway's (AHE) A-shares with an OUTPERFORM rating and a target price of Rmb17.32, implying 2025e and 2026e dividend yields of 4.0% and 4.4%. We resume coverage of its H- shares with a target price of HK$15.12, implying 2025e and 2026e dividend yields of 5.0% and 5.6%. AHE is the only A-H dual-listed toll road company in Anhui Province. Potential catalysts: Increases in the vehicle tr ...

Accessibility StatementSkip Navigation SYDNEY and SHANGHAI, Nov. 27, 2025 /PRNewswire/ -- Imugene Ltd (ASX:IMU), a clinical-stage immuno-oncology company, and JW Therapeutics (Shanghai) Co., LTD (HKEX:2126), a leading biotechnology company focused on cell-based immunotherapies, today announced a co-development collaboration to evaluate the combination of Imugene's oncolytic virus CF33-CD19 (onCARlytics) and JW's Carteyva®—a CD19- directed autologous CAR-T cell therapy—for patients with advanced solid tumors ...

Ross Gerber, co-founder of investment firm Gerber Kawasaki, has weighed in on the progress made by Elon Musk's Tesla Inc. (NASDAQ:TSLA) , as well as Robotaxi rival Alphabet Inc.'s (NASDAQ:GOOGL) (NASDAQ:GOOG) Waymo in the Robotaxi and self-driving sectors. Tesla FSD v14.2 Impressed Ross Gerber Taking to the social media platform X on Thursday, Gerber shared his experiences with the FSD system, saying that the technology "drives much better than before." However, the investor did concede that there were stil ...

Several biotech and life sciences companies posted notable gains in after-hours trading on Wednesday, November 26, reflecting investor interest despite a relatively quiet news cycle. Modular Medical, Inc. (MODD) shares surged in after-hours trading on November 26, climbing 11.51% to $0.4380. This rebound followed a modest decline of 1.80% at the close, where the stock ended at $0.3928. While no fresh news was released on Wednesday, investors may still be reacting to the company's November 17 announcement of ...

The Sunday Investor is focused exclusively on U.S. Equity ETFs. He has a strong analytical background, has received a Certificate of Advanced Investment Advice from the Canadian Securities Institute, and has completed all the educational requirements for the Chartered Investment Manager designation.Having covered hundreds of ETFs on Seeking Alpha, The Sunday Investor has developed a complex, proprietary ETF Rankings system which he shares on his website, etf-rankings.com. Nearly 1,000 ETFs receive individua ...